JGJianren Gu

Jianren Gu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jianren Gu has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Dafang Wan

    National Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University b , Medical School, Shanghai, 200032, China

    3 shared publications
  • Fei-Han Dai

    National Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, 25/Ln 2200, Xie Tu Road, 200032, Shanghai, P.R. China

    2 shared publications
  • Sheng-Li Yang

    Chinese Academy of Sciences

    2 shared publications
  • Wenxin Qin

    National Laboratory for Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao-Tong University Medical School, Shanghai 200032, PR China

    2 shared publications
  • Yan Chen

    Chinese Academy of Sciences

    2 shared publications
  • Yi Gong

    Chinese Academy of Sciences

    2 shared publications

Latest Publications

  • Open Access

    HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma

    by Feng Xue, Brandon W. Higgs, Jiaqi Huang, Chris Morehouse, Wei Zhu, Xin Yao, Philip Brohawn, Zhan Xiao, Yinong Sebastian, Zheng Liu, et al.

    Orthotopic liver transplantation (OLT) can be an effective treatment option for certain patients with early stage hepatocellular carcinoma (HCC) meeting Milan, UCSF, or Hangzhou criteria. However, HCC recurrence rates post-OLT range from 20 to 40 %, with limited follow-up options. Elucidating genetic drivers common to primary and post-OLT recurrent tumors may further our understanding and help identify predictive biomarkers of recurrence—both to ultimately help manage clinical decisions for patients undergoing OLT. Whole exome and RNA sequencing in matched primary and recurrent tumors, normal adjacent tissues, and blood from four Chinese HCC patients was conducted. SiRNA knockdown and both qRT-PCR and Western assays were performed on PLCPRF5, SNU449 and HEPG2 cell lines; immunohistochemistry and RNA Sequencing were conducted on the primary tumors of Chinese HCC patients who experienced tumor recurrence post-OLT (n = 9) or did not experience tumor recurrence (n = 12). In three independent HCC studies of patients undergoing transplantation (n = 21) or surgical resection (n = 242, n = 44) of primary tumors (total n = 307), HERC5 mRNA under-expression correlated with shorter: time to tumor recurrence (p = 0.007 and 0.02) and overall survival (p = 0.0063 and 0.023), even after adjustment for relevant clinical variables. HERC5 loss drives CCL20 mRNA and protein over-expression and associates with regulatory T cell infiltration as measured by FOXP3 expression. Further, matched primary and recurrent tumors from the 4 HCC patients indicated clonal selection advantage of Wnt signaling activation and CDKN2A inactivation. HERC5 plays a crucial role in HCC immune evasion and has clinical relevance as a reproducible prognostic marker for risk of tumor recurrence and survival in patients.


  • A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry

    by Peiyuan Yin, Dafang Wan, Chunxia Zhao, Jing Chen, Xinjie Zhao, Wenzhao Wang, Xin Lu, Shengli Yang, Jianren Gu, Guowang Xu

    Liver cirrhosis and hepatocellular carcinoma (HCC) are fatal sequelaes of chronic hepatitis B in China. The sera from HCC and cirrhosis were profiled by rapid resolution liquid chromatography coupled with quadrupole time-of-flight (Q-TOF) mass spectrometry. Reversed-phased (RP) liquid chromatography and hydrophilic interaction chromatography (HILIC) were used for the data acquisition. The normalized and combined data were handled by chemometric analysis, and the combination proved to be effective and reliable for the orthogonal projection to latent structures (OPLS) analysis. Metabonomic profiles and the potential biomarkers were found based on the OPLS models. Shared and unique structure (SUS) plots were used for the evaluation of the potential biomarkers. Glycocholic acid, glycochenodeoxycholic acid, taurocholic acid and taurochenodesoxycholic acid were found to be potential biomarkers related to liver cirrhosis, while dihydrosphingosine and phytosphingosine were potential diagnostic biomarkers of HCC. The other identified metabolites were considered as common potential biomarkers for the two liver diseases. Correlation networks based on these metabolites were also built for the systemic understanding of these diseases and the possible biological implications are discussed. This metabonomic approach may provide insight into discovery and identification of new diagnostic biomarkers for liver cancer and associated diseases.


  • Construction of an EGF receptor-mediated histone H1 0 -based gene delivery system

    by Fei-Han Dai, Yan Chen, Chang-Chun Ren, Jin-Jun Li, Min Yao, Jun-Song Han, Yi Gong, Sheng-Li Yang, Jing-De Zhu, Jian-Ren Gu

    To construct an EGF receptor (EGF-R)-mediated histone H10-based gene delivery system for gene therapy. A recombinant DNA containing histone H10, EGF-R ligand, and endosomalytic domains was constructed in a prokaryotic vector and expressed in E. coli. Expression of the β-galactosidase (β-gal) gene in the tumor cells and tissues was observed after transduction of the β-gal gene packaged by purified fusion proteins in vitro and in vivo. As an extension of the research on previously reported chemically synthetic composite polypeptide gene delivery systems, this genetically engineered polypeptide has proved to be capable of targeting the β-galactosidase (β-gal) gene into EGF-R-positive cancer cells both in vitro and in vivo. We also studied the time course of β-gal gene expression in tumor tissues delivered in vivo by this polypeptide vector. At 24 h after administration, expression of the β-galactosidase gene in tumor reached peak levels. The dosage optimization of administered polyplex was also investigated. The optimal dose of polyplex per mouse was 1 μg DNA packaged by 3 μg of composite polypeptide. The genetically engineered polypeptide based on histone H10 is a promising gene delivery system targeting EGF-R.


  • BNIPL-2, a novel homologue of BNIP-2, interacts with Bcl-2 and Cdc42GAP in apoptosis

    by Wenxin Qin, Jian Hu, Minglei Guo, Jian Xu, Jinjun Li, Genfu Yao, Xiaomei Zhou, Huiqiu Jiang, Pingping Zhang, Li Shen, et al.


  • Cloning and characterization of human IC53-2, a novel CDK5 activator binding protein

    by Yi Hu Xie, Xiang Huo He, Yun Tian Tang, Jin Jun Li, Zhi Mei Pan, Wen Xin Qin, Da Fang Wan, Jian Ren Gu

    Cell death and differentiation is a monthly research journal focused on the exciting field of programmed cell death and apoptosis. It provides a single accessible source of information for both scientists and clinicians, keeping them up-to-date with advances in the field. It encompasses programmed cell death, cell death induced by toxic agents, differentiation and the interrelation of these with cell proliferation.


  • Open Access

    Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis

    by Jian Yu, Min Ni, Jian Xu, Hongyu Zhang, Baomei Gao, Jianren Gu, Jianguo Chen, Lisheng Zhang, Mengchao Wu, Sushen Zhen, et al.

    Hepatocellular carcinoma (HCC) presents one of the major health threats in China today. A better understanding of the molecular genetics underlying malignant transformation of hepatocytes is critical to success in the battle against this disease. The methylation state of C5 of the cytosine in the CpG di-nucleotide that is enriched within or near the promoter region of over 50 % of the polymerase II genes has a drastic effect on transcription of these genes. Changes in the methylation profile of the promoters represent an alternative to genetic lesions as causative factors for the tumor-specific aberrant expression of the genes. We have used the methylation specific PCR method in conjunction with DNA sequencing to assess the methylation state of the promoter CpG islands of twenty genes. Aberrant expression of these genes have been attributed to the abnormal methylation profile of the corresponding promoter CpG islands in human tumors. While the following sixteen genes remained the unmethylated in all tumor and normal tissues: CDH1, APAF1, hMLH1, BRCA1, hTERC, VHL, RARβ, TIMP3, DAPK1, SURVIVIN, p14ARF, RB1, p15INK4b, APC, RASSF1c and PTEN, varying degrees of tumor specific hypermethylation were associated with the p16INK4a , RASSF1a, CASP8 and CDH13 genes. For instance, the p16INK4a was highly methylated in HCC (17/29, 58.6%) and less significantly methylated in non-cancerous tissue (4/29. 13.79%). The RASSF1a was fully methylated in all tumor tissues (29/29, 100%), and less frequently methylated in corresponding non-cancerous tissue (24/29, 82.75%). Furthermore, co-existence of methylated with unmethylated DNA in some cases suggested that both genetic and epigenetic (CpG methylation) mechanisms may act in concert to inactivate the p16INK4a and RASSF1a in HCC. Finally, we found a significant association of cirrhosis with hypermethylation of the p16INK4a and hypomethylation of the CDH13 genes. For the first time, the survey was carried out on such an extent that it would not only provide new insights into the molecular mechanisms underscoring the aberrant expression of the genes in this study in HCC, but also offer essential information required for a good methylation-based diagnosis of HCC.


    • 1 November 2002
      • Vol. 34  (6) , 800-3

    [Expression of histone-based fusion protein HNHG in E.coli].

    by Fei-Han Dai, Yan Chen, Yi Gong, Sheng-Li Yang, Pei-Kun Tian, Jian-Ren Gu

    Histone H1 contributes to condense nucleosome into super-structure during the transformation of chromatin into chromosome. It is shown in this rep or t that the fusion protein HNHG with the core of C-terminus of histone H1(0) expressed in BL21 (DE3) could also condense the plasmid DNA, just as histones did in nucleus. Under electron microscope, plasmid DNA condensed and supercoiled after t he addition of HNHG, in contrast to plasmid DNA control. This specific ability of the fusion protein HNHG of binding and condensing plasmids could be utilized to construct novel exogenous gene delivery systems. HNHG would be a promising candidate for gene delivery.

  • Computational analysis and prediction for exons of PAC579 genomic sequence

    by Yi Huang, Wenxin Qin, Dafang Wan, Xintai Zhao, Jianren Gu